Figure 3.Forest plot assessing the association between PD-L1 expression and sensitivity of androgen deprivation therapy (CRPC VS HSPC).
Figure 3 — The clinicopathological significance and prognostic value of programmed death-ligand 1 in prostate cancer: a meta-analysis of 3133 patients | Aging
